Breaking News

Capsugel, Cardax Collaborate on Astaxanthin Development

To develop novel formulations to enhance bioavailability

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Capsugel and Cardax, Inc. have entered a collaboration to develop and commercialize nature-identical synthetic formulations of astaxanthin products with pharmaceutical-grade purity that will provide improved oral bioavailability compared with other marketed astaxanthin products. Astaxanthin is used as a specialized antioxidant.   The astaxanthin products will be jointly developed using Capsugel’s lipid multi-particulate (LMP) technology, which encapsulates dissolved or suspended active ingredien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters